On 22 April, Happitech will join the 2026 Stanford Biodesign New Arrhythmia Technologies Retreat in Chicago. CEO @ysharb and team will present our approach to smartphone-based heart rhythm monitoring and medtech innovation. #StanfordBiodesign#AtrialFibrillation#Arrhythmia
“Check je hartritme” is now live in 6 Dutch cardiology hospitals. Aligned with ESC/EHRA #PulseDay2026, posters link AF awareness to action: scan the QR code to access smartphone PPG heart rhythm assessment in the @Luscii1 app, powered by Happitech.
Selected Dutch🫀hospitals will run the “Check je hartritme” campaign (2–15 March), led by Dr Stefan Timmer and Quinta Steenbergen @noordwestzh supported by @Luscii1 & Happitech. Smartphone PPG AF screening plus clearer GP follow-up aims to shorten time to AF diagnosis.
Happitech turns a smartphone camera into a clinically validated PPG tool for AF monitoring. Patients get at-home readings between appointments. Health systems get CE-marked, hardware-free monitoring that integrates with RPM and virtual care for scalable follow-up and triage.
Advancing cardiac research with smartphone-based monitoring.
Happitech’s FastStart app turns smartphones into a CE-certified, TGA-approved tool for remote AF, heart rate and HRV measurements, supporting scalable, real-world studies across the EU and US. #digitalcardiology
PPG is at the heart of Happitech’s smartphone-based cardiac monitoring. We will be at ESC Digital & AI Summit 2025 in Berlin (21–22 Nov) and would like to meet researchers and innovators working on PPG, digital biomarkers and AI in cardiology. #ESCAIsummit2025#ESC
At Noordwest Ziekenhuisgroep, cardiologists use Happitech's app (via Luscii platform) to support 🫀rhythm-based triage for cardioversion/ablation and post-treatment monitoring - reducing routine follow-ups while maintaining oversight in AF care.
📍Join us at #EHRA2025 in Vienna!
We’re advancing AF research with our clinically validated, AI-powered smartphone app - already used in studies across the EU, UK & USA.
Let’s connect if you're exploring digital tools for remote heart rhythm monitoring.
#EHRA2025#mHealth
Truly an honor to have shared the stage with giants in the field. Post-ablation AAD strategy is under investigated, an area that should be given more consideration in future studies. @jobrachmann @mbelshazly @drjohnm@JonHsuMD@jhurwitz55@deering_f@nmarrouche
30d-monitor sensitivity= 60%
#TelecheckAF asked pts to do #smartphone#PPG post ablation: avg’d 20 PPGs/week!
But compliance ⬇️ w/ ⬆️ duration/frequency of monitoring
#Smartwatch PPG algorithms could allow for 56 “pulse checks”/day *passively*!
@PassmanRod#WAFib2025
In anticoagulated patients with #AFib, bleeding was strongly associated with new cancer diagnoses.
Timely investigations after 🩸is of essence and should not be considered an expected adverse effect!
👏@husam247@CircAHA@JacopoImberti
In pts w/ subclinical #Afib & prior stroke/TIA enrolled in @Artesia_RCT, apixaban ⬇️ stroke/systemic TE risk by 7% over 3.5 yrs vs. ASA (1% in those w/o prior stroke/TIA). Major bleeding risk ⬆️by 3%
🖇️https://t.co/s1N6WpGCEr
@WFMMD@PHRIresearch@BorianiGiuseppe